Why the study?
Tools for risk stratification after cardiovascular interventions are crucial, and the prognostic potential of the biomarker MR-proADM in patients undergoing elective cardiac surgery required investigation.
Does preoperative MR-proADM level predict the composite of hospitalization for heart failure or cardiovascular mortality in patients undergoing elective cardiac surgery?
Population
500 patients undergoing elective cardiac bypass and/or valve surgery
Comparison
MR-proADM risk categories: Low Risk vs Intermediate Risk vs High Risk
Design
Prospective cohort study
Follow-up
5 years
Authors
Loading...
May aid preoperative risk stratification in elective cardiac surgery; hypothesis-generating pending prospective validation.
Does preoperative MR-proADM level predict the composite of hospitalization for heart failure or cardiovascular mortality in patients undergoing elective cardiac surgery?
Preoperative MR-proADM levels strongly predict 5-year cardiovascular mortality and heart failure hospitalization in patients undergoing elective cardiac surgery.
Baumer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: